{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:15:34Z","timestamp":1789532134401,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Primary vitreoretinal lymphoma is a great masquerader and provides a diagnostic challenge.<\/jats:p>\n            <jats:p>It is most frequently misdiagnosed as a chronic uveitis. Steroid treatment for presumed uveitis can interfere with the correct diagnosis of vitreoretinal lymphoma. Herein, we present a case of primary vitreoretinal lymphoma in which the correct diagnosis was delayed by short-term steroids until 2 years later.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 45-year-old woman presented with floaters and blurred vision in her right eye for 3 months. An ocular examination revealed dense vitreous cells. Three months later, she developed headache and suicidal ideation after taking a 3-week medication of oral steroid medication from another eye clinic. Brain magnetic resonance imaging revealed a tumor involving the corpus callosum and periventricular region.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Vitreous biopsy and repeated brain biopsies were carried out for the patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>A brain biopsy was performed for the first time, and a vitreous biopsy was performed when steroid medication was suspended for 20 and 41 days, respectively. Both biopsies were negative for the presence of malignant cells. Follow-up magnetic resonance imaging revealed complete remission of the brain tumor. Two years later, the tumor recurred in the optic chiasm. Diffuse large B-cell lymphoma was confirmed by a second brain biopsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome:<\/jats:title>\n            <jats:p>The patient had complete tumor remission after receiving brain radiation therapy and chemotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Vitreoretinal lymphoma is difficult to diagnose owing to its rarity, masquerading presentation, and steroid-induced apoptosis of lymphoma cells. Physicians should consider vitreoretinal lymphoma as an important differential diagnosis in patients presenting with chronic uveitis and use steroids cautiously before making a definitive diagnosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029637","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:02:02Z","timestamp":1658498522000},"page":"e29637","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Steroid-induced delayed diagnosis of primary vitreoretinal lymphoma with ghost brain tumor: A case report"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9811-4756","authenticated-orcid":false,"given":"Hui-Chuan","family":"Kau","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan"},{"name":"Department of Ophthalmology, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-3387","authenticated-orcid":false,"given":"Chieh-Chih","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan"},{"name":"Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/107327480401100502","article-title":"Intraocular lymphoma: update on diagnosis and management","volume":"11","author":"Chan","year":"2004","journal-title":"Cancer Control"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/OPTH.S159014","article-title":"Primary vitreoretinal lymphoma: prevalence, impact, and management challenges","volume":"13","author":"Venkatesh","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0161-6420(93)31469-7","article-title":"Intraocular lymphoma. Clinical and histopathologic diagnosis","volume":"100","author":"Whitcup","year":"1993","journal-title":"Ophthalmology"},{"key":"R4-20250504","first-page":"93","article-title":"Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma","volume":"15","author":"Chan","year":"2013","journal-title":"Discov Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaophthalmol.2013.569","article-title":"Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytological features, treatment, and outcomes","volume":"131","author":"Levasseur","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood.2020008235","article-title":"Primary vitreoretinal lymphoma: a diagnostic and management challenge","volume":"138","author":"Soussain","year":"2021","journal-title":"Blood"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/annonc\/mdm340","article-title":"Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report","volume":"18","author":"Grimm","year":"2007","journal-title":"Ann Oncol"},{"key":"R8-20250504","first-page":"446","article-title":"Improving the diagnostic yield of vitrectomy for intraocular lymphoma","volume":"118","author":"Sm","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","article-title":"The diagnosis and treatment of primary vitreoretinal lymphoma: a review","volume":"4","author":"Pulido","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.3390\/cancers13163921","article-title":"Vitreoretinal lymphoma","volume":"13","author":"Sobolewska","year":"2021","journal-title":"Cancers"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","article-title":"Consensus recommendations for the diagnosis of vitreoretinal lymphoma","volume":"29","author":"Carbonell","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1005733416571","article-title":"Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review the literature","volume":"32","author":"Pirotte","year":"1997","journal-title":"J Neurooncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1186\/s12885-021-08515-y","article-title":"Influence of preoperative corticosteroid treatment on rate of diagnostic surgeries in primary central nervous system lymphoma: a multicenter retrospective study","volume":"21","author":"Scheichel","year":"2021","journal-title":"BMC Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:20:44Z","timestamp":1746332444000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":13,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029637","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}